Epstein Secrets

gal activity continues. Also designed to cover up SEC corruption while screwing the whistleblower who caught them: ME. Recall: the above referenced Oppenheimer AML preliminary Denial of award by Norberg et al: "SEC Staff never saw Mr Dilorio's information" only AFTER using my information for 5 (FIVE) years. Not

My 2013 Knight/UBS TCR filed with Berger Montague in March 2013. Highlighted trading activity in Imaging Diagnostic Systems: IMDS. Despite glaring AML Red Flags involving entities subsequently cited by the SEC as Securities law violators, NITE and UBSS traded billions of shares. The SEC: Boston Director Leve

gal activity continues. Also designed to cover up SEC corruption while screwing the whistleblower who caught them: ME. Recall: the above referenced Oppenheimer AML preliminary Denial of award by Norberg et al: "SEC Staff never saw Mr Dilorio's information" only AFTER using my information for 5 (FIVE) years. Not

My 2013 Knight/UBS TCR filed with Berger Montague in March 2013. Highlighted trading activity in Imaging Diagnostic Systems: IMDS. Despite glaring AML Red Flags involving entities subsequently cited by the SEC as Securities law violators, NITE and UBSS traded billions of shares. The SEC: Boston Director Leve

gal activity continues. Also designed to cover up SEC corruption while screwing the whistleblower who caught them: ME. Recall: the above referenced Oppenheimer AML preliminary Denial of award by Norberg et al: "SEC Staff never saw Mr Dilorio's information" only AFTER using my information for 5 (FIVE) years. Not

My 2013 Knight/UBS TCR filed with Berger Montague in March 2013. Highlighted trading activity in Imaging Diagnostic Systems: IMDS. Despite glaring AML Red Flags involving entities subsequently cited by the SEC as Securities law violators, NITE and UBSS traded billions of shares. The SEC: Boston Director Leve

gal activity continues. Also designed to cover up SEC corruption while screwing the whistleblower who caught them: ME. Recall: the above referenced Oppenheimer AML preliminary Denial of award by Norberg et al: "SEC Staff never saw Mr Dilorio's information" only AFTER using my information for 5 (FIVE) years. Not

My 2013 Knight/UBS TCR filed with Berger Montague in March 2013. Highlighted trading activity in Imaging Diagnostic Systems: IMDS. Despite glaring AML Red Flags involving entities subsequently cited by the SEC as Securities law violators, NITE and UBSS traded billions of shares. The SEC: Boston Director Leve

gal activity continues. Also designed to cover up SEC corruption while screwing the whistleblower who caught them: ME. Recall: the above referenced Oppenheimer AML preliminary Denial of award by Norberg et al: "SEC Staff never saw Mr Dilorio's information" only AFTER using my information for 5 (FIVE) years. Not

My 2013 Knight/UBS TCR filed with Berger Montague in March 2013. Highlighted trading activity in Imaging Diagnostic Systems: IMDS. Despite glaring AML Red Flags involving entities subsequently cited by the SEC as Securities law violators, NITE and UBSS traded billions of shares. The SEC: Boston Director Leve

gal activity continues. Also designed to cover up SEC corruption while screwing the whistleblower who caught them: ME. Recall: the above referenced Oppenheimer AML preliminary Denial of award by Norberg et al: "SEC Staff never saw Mr Dilorio's information" only AFTER using my information for 5 (FIVE) years. Not

My 2013 Knight/UBS TCR filed with Berger Montague in March 2013. Highlighted trading activity in Imaging Diagnostic Systems: IMDS. Despite glaring AML Red Flags involving entities subsequently cited by the SEC as Securities law violators, NITE and UBSS traded billions of shares. The SEC: Boston Director Leve

gal activity continues. Also designed to cover up SEC corruption while screwing the whistleblower who caught them: ME. Recall: the above referenced Oppenheimer AML preliminary Denial of award by Norberg et al: "SEC Staff never saw Mr Dilorio's information" only AFTER using my information for 5 (FIVE) years. Not

My 2013 Knight/UBS TCR filed with Berger Montague in March 2013. Highlighted trading activity in Imaging Diagnostic Systems: IMDS. Despite glaring AML Red Flags involving entities subsequently cited by the SEC as Securities law violators, NITE and UBSS traded billions of shares. The SEC: Boston Director Leve

gal activity continues. Also designed to cover up SEC corruption while screwing the whistleblower who caught them: ME. Recall: the above referenced Oppenheimer AML preliminary Denial of award by Norberg et al: "SEC Staff never saw Mr Dilorio's information" only AFTER using my information for 5 (FIVE) years. Not

My 2013 Knight/UBS TCR filed with Berger Montague in March 2013. Highlighted trading activity in Imaging Diagnostic Systems: IMDS. Despite glaring AML Red Flags involving entities subsequently cited by the SEC as Securities law violators, NITE and UBSS traded billions of shares. The SEC: Boston Director Leve